Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease

1993 ◽  
Vol 14 (1) ◽  
pp. 45-74 ◽  
Author(s):  
David Waters ◽  
Lyall Higginson ◽  
Peter Gladstone ◽  
Brian Kimball ◽  
Michel LeMay ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Clinical Trial ◽  
Coronary Artery ◽  
Reductase Inhibitor ◽  
Controlled Clinical Trial ◽  
Design Features ◽  
Hmg Coa Reductase ◽  
Hmg Coa Reductase Inhibitor ◽  
Artery Disease ◽  
Coa Reductase

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1999 ◽  
Vol 147 (2) ◽  
pp. 237-242 ◽  
Author(s):  
Mikko J Järvisalo ◽  
Jyri O Toikka ◽  
Tommi Vasankari ◽  
Jorma Mikkola ◽  
Jorma S.A Viikari ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Endothelial Function ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Artery Disease ◽  
Coa Reductase
Sign in / Sign up

Export Citation Format

Share Document